|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||
| Investments at Fair Value | |||||||||||||||
| Controlled | |||||||||||||||
| Affiliated | |||||||||||||||
| Non-affiliated | |||||||||||||||
| Total investments at Fair Value | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Restricted cash | |||||||||||||||
| Deferred offering costs | |||||||||||||||
| Interest and dividends receivable | |||||||||||||||
| Receivable for unsettled trades | |||||||||||||||
| Capital call receivable | |||||||||||||||
| Prepaid expenses and other assets | |||||||||||||||
| Due from broker | |||||||||||||||
| Total assets | |||||||||||||||
| Liabilities: | |||||||||||||||
| Debt (net of deferred financing costs of $16,280 and $14,922, respectively) | |||||||||||||||
| Short-term borrowings | |||||||||||||||
| Secured borrowings | |||||||||||||||
| Management fees payable | |||||||||||||||
| Incentive fees on income payable | |||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||
| Payable for unsettled trades | |||||||||||||||
| Stockholder distributions payable | |||||||||||||||
| Interest and debt fees payable | |||||||||||||||
| Directors' fees payable | |||||||||||||||
| Other liabilities | |||||||||||||||
| Unrealized loss on derivatives | |||||||||||||||
| Total liabilities | |||||||||||||||
| Redeemable convertible preferred stock Series A, $0.001 par value, 50,000,000 shares authorized; 77,500 issued and outstanding at both June 30, 2026 and December 31, 2025 | |||||||||||||||
| Series A Preferred Stock | |||||||||||||||
| Total redeemable convertible preferred stock Series A, $0.001 par value, 50,000,000 shares authorized; 77,500 issued and outstanding at both June 30, 2026 and December 31, 2025 | |||||||||||||||
| Net assets attributable to common stock: | |||||||||||||||
| Common stock, $0.001 par value, 450,000,000 shares authorized; $133,482,448 issued and outstanding at June 30, 2026, and $135,487,319 issued and outstanding at December 31, 2025 | |||||||||||||||
| Additional paid in capital | |||||||||||||||
| Total distributable earnings (loss) | |||||||||||||||
| Total net assets attributable to common stock | |||||||||||||||
| Total liabilities, redeemable convertible preferred stock, and net assets attributable to common stock | |||||||||||||||
| Net asset value per share attributable to common stock (in dollar per share) |
Loading...
